1-day, in-person course
CPD accreditation is being sought (6 CPD hours)
Aims:
Health-related quality of life (QoL) is an essential outcome in contemporary clinical trials. This course will provide an overview of QoL assessment in oncology, including selecting appropriate QoL instruments and implementing, analysing, and interpreting QoL data across trial phases (I–III) and real-world studies.
The course will also cover incorporating QoL into grant applications and protocols, and its use in decision-making to support the implementation of new interventions into clinical practice (e.g. surgery or radiotherapy) or for market authorisation and market access of new cancer drugs. Sessions will be interactive and based on real-life examples.
Target Audience:
This course is for researchers, clinicians, healthcare professionals and statisticians from universities, pharmaceutical companies, NHS, and regulatory and health technology assessment agencies. No prior knowledge of quality of life is required.
The course will be delivered by experts with extensive experience in designing and reporting cancer studies involving QoL, and with a strong track record in teaching:
Dr Andre Lopes – Associate Professor in Medical Statistics with over 12 years’ experience in cancer clinical trials; Teaching & Education Lead for the Cancer Trials Centre; member of the EORTC Quality of Life Group.
Professor Allan Hackshaw – Director of the CRUK and UCL Cancer Trials Centre, with over 32 years’ experience in practice-changing cancer studies; teaches evidence-based medicine and clinical trials at UCL and LSE, including courses on market access to pharmaceutical companies.
Dr Sally Wheelwright – Principal Research Fellow at Brighton and Sussex Medical School, with 30 years’ research experience, including 15 in QoL; senior researcher at the Sussex Health Outcomes Research and Education in Cancer (SHORE-C) group; member of the EORTC QoL workgroup.